Centrum Medyczne ENEL-MED S.A. (ENE.WA)
PLN 20.0
(4.17%)
PLN 20.0
(4.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 91.1 Million PLN | 51.99% |
| 2022 | 40 Million PLN | -31.89% |
| 2021 | 63.31 Million PLN | 0.76% |
| 2020 | 60.01 Million PLN | -4.45% |
| 2019 | 63.05 Million PLN | 165.99% |
| 2018 | 23.38 Million PLN | 30.65% |
| 2017 | 17.82 Million PLN | -13.43% |
| 2016 | 20.94 Million PLN | 40.38% |
| 2015 | 14.11 Million PLN | -5.41% |
| 2014 | 15.11 Million PLN | -9.57% |
| 2013 | 17.75 Million PLN | 144.76% |
| 2012 | 7.28 Million PLN | -61.93% |
| 2011 | 17.95 Million PLN | 26.56% |
| 2010 | 13.71 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 19.82 Million PLN | -28.53% |
| 2024 Q2 | 23.33 Million PLN | 2.25% |
| 2023 Q1 | 12.1 Million PLN | -4.9% |
| 2023 Q4 | 17.42 Million PLN | -23.64% |
| 2023 Q3 | 22.82 Million PLN | -31.94% |
| 2023 Q2 | 33.52 Million PLN | 177.05% |
| 2023 FY | - PLN | 51.99% |
| 2022 Q1 | 9.55 Million PLN | -42.0% |
| 2022 FY | - PLN | -31.89% |
| 2022 Q4 | 12.72 Million PLN | -33.74% |
| 2022 Q3 | 19.2 Million PLN | 282.34% |
| 2022 Q2 | 5.02 Million PLN | -47.4% |
| 2021 FY | - PLN | 0.76% |
| 2021 Q4 | 16.46 Million PLN | 13.63% |
| 2021 Q1 | 15.51 Million PLN | 252.55% |
| 2021 Q3 | 14.49 Million PLN | -12.36% |
| 2021 Q2 | 16.53 Million PLN | 6.58% |
| 2020 Q3 | 19.11 Million PLN | -42.17% |
| 2020 Q1 | 3.4 Million PLN | -83.13% |
| 2020 Q4 | 4.4 Million PLN | -76.99% |
| 2020 FY | - PLN | -4.45% |
| 2020 Q2 | 33.06 Million PLN | 870.93% |
| 2019 Q4 | 20.18 Million PLN | 27.79% |
| 2019 FY | - PLN | 165.99% |
| 2019 Q2 | 15.47 Million PLN | 24.95% |
| 2019 Q1 | 12.38 Million PLN | 70.08% |
| 2019 Q3 | 15.79 Million PLN | 2.11% |
| 2018 Q4 | 7.28 Million PLN | -20.62% |
| 2018 Q3 | 9.17 Million PLN | 285.34% |
| 2018 FY | - PLN | 30.65% |
| 2018 Q1 | 5.21 Million PLN | 593.47% |
| 2018 Q2 | 2.38 Million PLN | -54.33% |
| 2017 Q2 | 6.24 Million PLN | 2.56% |
| 2017 Q1 | 6.08 Million PLN | 40.76% |
| 2017 FY | - PLN | -13.43% |
| 2017 Q4 | -1.05 Million PLN | -116.12% |
| 2017 Q3 | 6.55 Million PLN | 4.98% |
| 2016 Q4 | 4.32 Million PLN | -46.99% |
| 2016 FY | - PLN | 40.38% |
| 2016 Q2 | 5.48 Million PLN | 83.59% |
| 2016 Q1 | 2.98 Million PLN | 64.16% |
| 2016 Q3 | 8.15 Million PLN | 48.76% |
| 2015 Q2 | 2.83 Million PLN | -41.97% |
| 2015 Q3 | 4.56 Million PLN | 61.05% |
| 2015 Q4 | 1.81 Million PLN | -60.19% |
| 2015 Q1 | 4.88 Million PLN | 61.83% |
| 2015 FY | - PLN | -5.41% |
| 2014 Q2 | 40.16 Million PLN | 865.95% |
| 2014 FY | - PLN | -9.57% |
| 2014 Q4 | 3.02 Million PLN | -44.2% |
| 2014 Q3 | 5.41 Million PLN | -86.52% |
| 2014 Q1 | 4.15 Million PLN | -11.76% |
| 2013 FY | - PLN | 144.76% |
| 2013 Q1 | 3.25 Million PLN | 156.13% |
| 2013 Q2 | 4.06 Million PLN | 24.8% |
| 2013 Q3 | 5.72 Million PLN | 40.78% |
| 2013 Q4 | 4.71 Million PLN | -17.68% |
| 2012 Q4 | 1.27 Million PLN | -66.39% |
| 2012 Q1 | 1.49 Million PLN | -65.31% |
| 2012 FY | - PLN | -61.93% |
| 2012 Q3 | 3.78 Million PLN | 459.91% |
| 2012 Q2 | 676 Thousand PLN | -54.81% |
| 2011 Q1 | 5.26 Million PLN | 63.05% |
| 2011 FY | - PLN | 26.56% |
| 2011 Q3 | 5.37 Million PLN | 35.09% |
| 2011 Q4 | 4.31 Million PLN | -19.82% |
| 2011 Q2 | 3.98 Million PLN | -24.32% |
| 2010 FY | - PLN | 0.0% |
| 2010 Q3 | 4.6 Million PLN | 0.0% |
| 2010 Q4 | 3.22 Million PLN | -29.88% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EMC Instytut Medyczny SA | 58.71 Million PLN | -55.164% |